Medical Psychedelics
The last decade has seen a newfound interest in the clinical applications of psychedelic substances such as LSD, psilocybin, MDMA, DMT, ayahuasca and ketamine—an interest not seen since pre-prohibition days.
Back then, these substances were widely used as adjuncts to psychotherapy in the treatment of severe psychiatric and psychological problems such as posttraumatic stress disorder (PTSD), depression and substance abuse.

The current results are extremely promising, and many believe we are on the verge of a new psychedelic revolution, which will transform the field of psychiatry. There is now a push to make these substances legal again, and a lot of great researchers are working to gather evidence of their safety and efficacy in various patient populations. This text presents an in-depth analysis of what is currently known about the possible medical applications of psychedelics.
It examines the pre- and post-prohibition medical literature as well as the manuals used in clinical research, and it focuses on the practical aspects of psychedelic-mediated therapy.

The aim is to update this analysis annually and thus to develop it—along with the ever-expanding body of evidence—into a textbook that can be used when/if these substances again become legal. It is intended for medical and psychological professionals, science-minded psychonauts and any other members of the public who want to know more about psychedelic substances.